Ionis Pharmaceuticals, Inc. Increase (Decrease) in Deferred Liabilities
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Deferred Liabilities of $125.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2017-03-01
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for the quarter ending 2016-06-30 was $53.00K, a 49.52% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for the quarter ending 2016-03-31 was $48.00K, a 22.58% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for the quarter ending 2015-12-31 was $42.00K, a 55.56% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for the quarter ending 2015-09-30 was -$4.00K, a 107.02% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was $125.00K, a 39.02% decline from fiscal 2015.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for fiscal 2015 was $205.00K, a 33.99% increase from fiscal 2014.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for fiscal 2014 was $153.00K, a 29.49% decline from fiscal 2013.
- Ionis Pharmaceuticals, Inc. increase (decrease) in deferred liabilities for fiscal 2013 was $217.00K, a 14.90% decline from fiscal 2012.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $125.00K 10-K · filed 2017-03-01 | |||
| 2016-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $101.00K 10-Q · filed 2016-08-09 | $143.00K derived: sum of 3 quarters · filed 2017-03-01 | $139.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-03-31 | $48.00K 10-Q · filed 2016-05-05 | $90.00K derived: sum of 2 quarters · filed 2017-03-01 | $86.00K derived: sum of 3 quarters · filed 2017-03-01 | $191.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $38.00K derived: sum of 2 quarters · filed 2017-03-01 | $143.00K derived: sum of 3 quarters · filed 2017-03-01 | $205.00K 10-K · filed 2017-03-01 |
| 2015-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $101.00K derived: sum of 2 quarters · filed 2016-08-09 | $163.00K 10-Q · filed 2015-11-09 | $190.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $167.00K 10-Q · filed 2016-08-09 | $194.00K derived: sum of 3 quarters · filed 2017-03-01 | $251.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $62.00K 10-Q · filed 2016-05-05 | $89.00K derived: sum of 2 quarters · filed 2017-03-01 | $146.00K derived: sum of 3 quarters · filed 2017-03-01 | $190.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $84.00K derived: sum of 2 quarters · filed 2017-03-01 | $128.00K derived: sum of 3 quarters · filed 2017-03-01 | $153.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $101.00K derived: sum of 2 quarters · filed 2015-11-09 | $126.00K 10-Q · filed 2015-11-09 | $170.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $69.00K 10-Q · filed 2015-08-05 | $113.00K derived: sum of 3 quarters · filed 2016-02-26 | $188.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $25.00K 10-Q · filed 2015-05-05 | $69.00K derived: sum of 2 quarters · filed 2016-02-26 | $144.00K derived: sum of 3 quarters · filed 2016-02-26 | $202.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $119.00K derived: sum of 2 quarters · filed 2016-02-26 | $177.00K derived: sum of 3 quarters · filed 2016-02-26 | $217.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $133.00K derived: sum of 2 quarters · filed 2014-11-07 | $173.00K 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $98.00K 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $40.00K 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $255.00K 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $382.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |